These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26590374)

  • 1. Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.
    Taylor DA; Perin EC; Willerson JT; Zierold C; Resende M; Carlson M; Nestor B; Wise E; Orozco A; Pepine CJ; Henry TD; Ellis SG; Zhao DX; Traverse JH; Cooke JP; Schutt RC; Bhatnagar A; Grant MB; Lai D; Johnstone BH; Sayre SL; Moyé L; Ebert RF; Bolli R; Simari RD; Cogle CR;
    Cell Transplant; 2016; 25(9):1675-1687. PubMed ID: 26590374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
    Perin EC; Willerson JT; Pepine CJ; Henry TD; Ellis SG; Zhao DX; Silva GV; Lai D; Thomas JD; Kronenberg MW; Martin AD; Anderson RD; Traverse JH; Penn MS; Anwaruddin S; Hatzopoulos AK; Gee AP; Taylor DA; Cogle CR; Smith D; Westbrook L; Chen J; Handberg E; Olson RE; Geither C; Bowman S; Francescon J; Baraniuk S; Piller LB; Simpson LM; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2012 Apr; 307(16):1717-26. PubMed ID: 22447880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-T I; Ortak J; Kische S; Akin I; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Belu C; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cell Rev Rep; 2011 Sep; 7(3):646-56. PubMed ID: 21188654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
    Cogle CR; Wise E; Meacham AM; Zierold C; Traverse JH; Henry TD; Perin EC; Willerson JT; Ellis SG; Carlson M; Zhao DX; Bolli R; Cooke JP; Anwaruddin S; Bhatnagar A; da Graca Cabreira-Hansen M; Grant MB; Lai D; Moyé L; Ebert RF; Olson RE; Sayre SL; Schulman IH; Bosse RC; Scott EW; Simari RD; Pepine CJ; Taylor DA;
    Circ Res; 2014 Oct; 115(10):867-74. PubMed ID: 25136078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
    Raval AN; Johnston PV; Duckers HJ; Cook TD; Traverse JH; Altman PA; Dhingra R; Hematti P; Borrello I; Anderson RD; Pepine CJ
    Int J Cardiol; 2021 Mar; 326():131-138. PubMed ID: 33091520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy.
    Park K; Lai D; Handberg EM; Moyé L; Perin EC; Pepine CJ; Anderson RD
    Tex Heart Inst J; 2016 Aug; 43(4):291-6. PubMed ID: 27547135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
    Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
    Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
    Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
    Bhatnagar A; Bolli R; Johnstone BH; Traverse JH; Henry TD; Pepine CJ; Willerson JT; Perin EC; Ellis SG; Zhao DX; Yang PC; Cooke JP; Schutt RC; Trachtenberg BH; Orozco A; Resende M; Ebert RF; Sayre SL; Simari RD; Moyé L; Cogle CR; Taylor DA;
    Am Heart J; 2016 Sep; 179():142-50. PubMed ID: 27595689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
    Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
    Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF).
    Santoso T; Siu CW; Irawan C; Chan WS; Alwi I; Yiu KH; Aziz A; Kwong YL; Tse HF
    J Cardiovasc Transl Res; 2014 Aug; 7(6):545-52. PubMed ID: 25079593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
    Heldman AW; DiFede DL; Fishman JE; Zambrano JP; Trachtenberg BH; Karantalis V; Mushtaq M; Williams AR; Suncion VY; McNiece IK; Ghersin E; Soto V; Lopera G; Miki R; Willens H; Hendel R; Mitrani R; Pattany P; Feigenbaum G; Oskouei B; Byrnes J; Lowery MH; Sierra J; Pujol MV; Delgado C; Gonzalez PJ; Rodriguez JE; Bagno LL; Rouy D; Altman P; Foo CW; da Silva J; Anderson E; Schwarz R; Mendizabal A; Hare JM
    JAMA; 2014 Jan; 311(1):62-73. PubMed ID: 24247587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.
    Willerson JT; Perin EC; Ellis SG; Pepine CJ; Henry TD; Zhao DX; Lai D; Penn MS; Byrne BJ; Silva G; Gee A; Traverse JH; Hatzopoulos AK; Forder JR; Martin D; Kronenberg M; Taylor DA; Cogle CR; Baraniuk S; Westbrook L; Sayre SL; Vojvodic RW; Gordon DJ; Skarlatos SI; Moyé LA; Simari RD;
    Am Heart J; 2010 Aug; 160(2):215-23. PubMed ID: 20691824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
    Hare JM; Fishman JE; Gerstenblith G; DiFede Velazquez DL; Zambrano JP; Suncion VY; Tracy M; Ghersin E; Johnston PV; Brinker JA; Breton E; Davis-Sproul J; Schulman IH; Byrnes J; Mendizabal AM; Lowery MH; Rouy D; Altman P; Wong Po Foo C; Ruiz P; Amador A; Da Silva J; McNiece IK; Heldman AW; George R; Lardo A
    JAMA; 2012 Dec; 308(22):2369-79. PubMed ID: 23117550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral Blood Biomarkers Associated With Improved Functional Outcome in Patients With Chronic Left Ventricular Dysfunction: A Biorepository Evaluation of the FOCUS-CCTRN Trial.
    Chacon Alberty L; Perin EC; Willerson JT; Gahremanpour A; Bolli R; Yang PC; Traverse JH; Lai D; Pepine CJ; Taylor DA
    Front Cardiovasc Med; 2021; 8():698088. PubMed ID: 34540912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure.
    Patel AN; Mittal S; Turan G; Winters AA; Henry TD; Ince H; Trehan N
    Stem Cells Transl Med; 2015 Sep; 4(9):1021-7. PubMed ID: 26217065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Marrow Mononuclear Cells Transfer for Patients after ST-Elevated Myocardial Infarction: A Meta-Analysis of Randomized Control Trials.
    Zhang J; Lin L; Zong W
    Yonsei Med J; 2018 Jul; 59(5):611-623. PubMed ID: 29869459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcome of Intra-Myocardial Injection of Autologous Bone Marrow Mononuclear Cells Combined with Isolated Coronary Artery Bypass Grafting for Patients with Chronic Ischemic Heart Failure.
    Wang R; Zhang L; Wang Y; Gong Z; Xiao C; Wu Y; Ren C; Cheng N; Gao C
    Heart Surg Forum; 2016 Jun; 19(3):E131-8. PubMed ID: 27355149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
    Perin EC; Dohmann HF; Borojevic R; Silva SA; Sousa AL; Mesquita CT; Rossi MI; Carvalho AC; Dutra HS; Dohmann HJ; Silva GV; Belém L; Vivacqua R; Rangel FO; Esporcatte R; Geng YJ; Vaughn WK; Assad JA; Mesquita ET; Willerson JT
    Circulation; 2003 May; 107(18):2294-302. PubMed ID: 12707230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy and bone marrow cell transplantation in patients with ischemic heart failure and electromechanical dyssynchrony: a randomized pilot study.
    Pokushalov E; Romanov A; Corbucci G; Prohorova D; Chernyavsky A; Larionov P; Terekhov I; Artyomenko S; Kliver E; Shirokova N; Karaskov A; Dib N
    J Cardiovasc Transl Res; 2011 Dec; 4(6):767-78. PubMed ID: 21547598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.